Home » Topics » Regulatory

Regulatory
RSS

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

Remicade recommended for approval in Europe for broader application

Oct. 26, 2000

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Oct. 24, 2000

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

Dimethaid Research seeks approval for topical osteoarthritis treatment in Canada

Oct. 18, 2000

Glucophage XR: once-daily type 2 diabetes drug approved by FDA

Oct. 18, 2000

Aradigm completes phase II trial with AERx delivery of dornase alfa for CF patients

Oct. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...